Oral absorption and lymphatic transport of baicalein following drug–phospholipid complex incorporation in self-microemulsifying drug delivery systems

References

• Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev. 2001;50(1):3–20.11489331
   PubMed Web of Science ®Google Scholar
• Porter C, Pouton CJ, Charman W, Charman WN. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673–691. doi:10.1016/j.addr.2007.10.01418155801
   PubMed Web of Science ®Google Scholar
• O’Driscoll CM. Lipid-based formulations for intestinal lymphatic delivery. Eur J Hosp Pharm. 2002;15(5):405–415.
   Google Scholar
• Caliph SM, Charman WN, Porter CJH. Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. J Pharm Sci. 2000;89(8):1073–1084. doi:10.1002/1520-6017(200008)89:8<1073::aid-jps12>3.0.co;2-v10906731
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997;25(1):47–58. doi:10.1016/S0169-409X(96)00490-5
   Web of Science ®Google Scholar
• Aboulfotouh K, Allam AA, El-Badry M, El-Sayed AM. Role of self-emulsifying drug delivery systems in optimizing the oral delivery of hydrophilic macromolecules and reducing interindividual variability. Colloids Surf B Biointerfaces. 2018;167(2018):82–92. doi:10.1016/j.colsurfb.2018.03.03429627681
   PubMedGoogle Scholar
• Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173–182. doi:10.1016/j.biopha.2004.02.00115082340
   PubMed Web of Science ®Google Scholar
• René H, Porter CJH, Edwards GA, Anette M, Kristensen HG, Charman WN. Examination of oral absorption and lymphatic transport of halofantrine in a triple-cannulated canine model after administration in self-microemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur J Hosp Pharm. 2003;20(1):91–97.
   Google Scholar
• Minghui S, Xuezhen Z, Kewen X, et al. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with or. Saudi Pharm J. 2011;43(3):132–140. doi:10.1016/j.ejps.2011.04.011
   Google Scholar
• Zhao L, Zhang L, Meng L, Wang J, Zhai G. Design and evaluation of a self-microemulsifying drug delivery system for apigenin. Drug Dev Ind Pharm. 2013;39(5):662–669. doi:10.3109/03639045.2012.68737822607130
   PubMed Web of Science ®Google Scholar
• Borhade V, Nair H, Hegde D. Design and evaluation of Self-Microemulsifying Drug Delivery System (SMEDDS) of tacrolimus. AAPS PharmSciTech. 2008;9(1):13–21. doi:10.1208/s12249-007-9014-818446456
   PubMed Web of Science ®Google Scholar
• Mandawgade SD, Sharma S, Pathak S, Patravale VB. Development of SMEDDS using natural lipophile: application to β-artemether delivery. Int J Pharm. 2008;362(1):179–183. doi:10.1016/j.ijpharm.2008.06.02118652886
   PubMedGoogle Scholar
• Zhang L, Zhang L, Zhang M, et al. Self-emulsifying drug delivery system and the applications in herbal drugs. Drug Deliv. 2013;22(4):475–486. doi:10.3109/10717544.2013.86165924321014
   PubMedGoogle Scholar
• Wu X, Xu J, Huang X, Wen C. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm. 2011;37(1):15. doi:10.3109/03639045.2010.48956020738181
   PubMed Web of Science ®Google Scholar
• Qiao J, Ji D, Sun S, et al. Oral bioavailability and lymphatic transport of pueraria flavone-loaded self-emulsifying drug-delivery systems containing sodium taurocholate in rats. Pharmaceutics. 2018;10(3):147. doi:10.3390/pharmaceutics10030147
   PubMed Web of Science ®Google Scholar
• Kimura Y, Okuda H, Arichi S. Effects of baicalein on leukotriene C4 biosynthesis in human lymphocytes. Phytother Res. 1987;1(1):48–49. doi:10.1002/(ISSN)1099-1573
   Google Scholar
• Yin J, Xiang C, Wang P, Yin Y, Hou Y. Biocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailability. Int J Nanomedicine. 2017;12:2923–2931. doi:10.2147/IJN.S13116728435268
   PubMed Web of Science ®Google Scholar
• Pi J, Wang S, Wen L, et al. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein. Asian J Pharm Sci. 2019;14(2):154-164. S1818087617309492-.
   Google Scholar
• Yan Z, Lei S, Yaping H, et al. Baicalein selectively induces apoptosis in activated lymphocytes and ameliorates concanavalin a-induced hepatitis in mice. PLoS One. 2013;8(7):e69592. doi:10.1371/journal.pone.006959223894507
   PubMedGoogle Scholar
• Lam HT, Le-Vinh B, Phan TNQ, Bernkop-Schnürch A. Self-emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity? J Pharm Pharmacol. 2019;71(2):156–166. doi:10.1111/jphp.1302130251762
   PubMed Web of Science ®Google Scholar
• Zhou H, Wan J, Wu L, et al. A new strategy for enhancing the oral bioavailability of drugs with poor water-solubility and low liposolubility based on phospholipid complex and supersaturated SEDDS. PLoS One. 2013;8(12):e84530. doi:10.1371/journal.pone.008453024391965
   PubMed Web of Science ®Google Scholar
• Wu H, Long X, Yuan F, et al. Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin. Acta Pharm Sin B. 2014;4(3):217–226. doi:10.1016/j.apsb.2014.03.00226579386
   PubMed Web of Science ®Google Scholar
• Zhou Y, Dong W, Ye J, et al. A novel matrix dispersion based on phospholipid complex for improving oral bioavailability of baicalein: preparation, in vitro and in vivo evaluations. Drug Deliv. 2017;24(1):720–728. doi:10.1080/10717544.2017.131196828436702
   PubMed Web of Science ®Google Scholar
• Khoo S-M, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167(1):155–164. doi:10.1016/S0378-5173(98)00054-4
   Web of Science ®Google Scholar
• Kadu PJ, Kushare SS, Thacker DD, Gattani SG. Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). Pharm Dev Technol. 2011;16(1):65–74. doi:10.3109/1083745090349933320088679
   PubMed Web of Science ®Google Scholar
• Singh B, Khurana L, Bandyopadhyay S, Kapil R, Katare OO. Development of optimized self-nano-emulsifying drug delivery systems (SNEDDS) of carvedilol with enhanced bioavailability potential. Drug Deliv. 2011;18(8):599–612. doi:10.3109/10717544.2011.60468622008038
   PubMed Web of Science ®Google Scholar
• Avachat AM, Patel VG. Self nanoemulsifying drug delivery system of stabilized ellagic acid–phospholipid complex with improved dissolution and permeability. Saudi Pharm J. 2015;23(3):276–289. doi:10.1016/j.jsps.2014.11.00126106276
   PubMed Web of Science ®Google Scholar
• Zhang P, Liu Y, Feng N, Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int J Pharm. 2008;355(1):269–276. doi:10.1016/j.ijpharm.2007.12.02618242895
   PubMedGoogle Scholar
• Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm. 2009;380(1):133–141. doi:10.1016/j.ijpharm.2009.07.01519635537
   PubMedGoogle Scholar
• Shen H, Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J Pharm Pharmacol. 2010;58(9):1183–1191. doi:10.1211/jpp.58.9.0004
   Google Scholar
• Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts. J Control Release. 2010;147(1):127–135. doi:10.1016/j.jconrel.2010.06.02220603167
   PubMed Web of Science ®Google Scholar
• Celia C, Trapasso E, Cosco D, Paolino D, Fresta M. Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent. Colloids Surf B Biointerfaces. 2009;72(1):155–160. doi:10.1016/j.colsurfb.2009.03.00719376689
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee Jschon SK, Jeong SY, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274(1):65–73. doi:10.1016/j.ijpharm.2003.12.02815072783
   PubMedGoogle Scholar
• Wenli L, Rui T, Wenjing H, et al. Preparation and evaluation of self-microemulsifying drug delivery system of baicalein. Fitoterapia. 2012;83(8):1532–1539. doi:10.1016/j.fitote.2012.08.02122982454
   PubMedGoogle Scholar
• Zupančič O, Partenhauser A, Lam HT, Rohrer J, Bernkop-Schnürch A. Development and in vitro characterisation of an oral self-emulsifying delivery system for daptomycin. Eur J Hosp Pharm. 2016;81:129–136. doi:10.1016/j.ejps.2015.10.005
   Google Scholar
• Zangenberg NH, Müllertz A, Kristensen HG, Hovgaard L. A dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calcium. Eur J Hosp Pharm. 2001;14(2):115–122.
   Google Scholar
• Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Controlled Release. 2008;129(1):1–10. doi:10.1016/j.jconrel.2008.03.021
   PubMed Web of Science ®Google Scholar
• Christensen JØ, Schultz K, Mollgaard B, Kristensen HG, Mullertza A. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols. Eur J Hosp Pharm. 2004;23(3):287–296. doi:10.1016/j.ejps.2004.08.003
   Google Scholar
• Zhang J, Lv H, Jiang K, Gao Y. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal. Int J Pharm. 2011;420(1):180–188. doi:10.1016/j.ijpharm.2011.08.02321878378
   PubMed Web of Science ®Google Scholar
• He X, Pei L, Tong HHY, Ying Z. Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with pluronic F68 to improve dissolution and oral bioavailability. AAPS PharmSciTech. 2011;12(1):104–113. doi:10.1208/s12249-010-9560-321181514
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo R, Chen Y, Ke X, Hu D, Han M. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion. AAPS PharmSciTech. 2014;15(3):560–568. doi:10.1208/s12249-013-0071-x24570374
   PubMedGoogle Scholar
• Fan Z, Wu J, Fang X, Sha X. A new function of vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons. Int J Pharm. 2013;445(1–2):141–147. doi:10.1016/j.ijpharm.2013.01.07023396256
   PubMedGoogle Scholar
• Lind ML, Jette J, René H, Anette M. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80. Saudi Pharm J. 2008;35(3):211–218. doi:10.1016/j.ejps.2008.07.003
   Google Scholar
• Vivek M, Rashmi J, Komal P, Manish N, Amita J. Solid lipid nanoparticles (SLN) of efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. 2015;495(1):439–446. doi:10.1016/j.ijpharm.2015.09.01426367780
   PubMedGoogle Scholar
• Dahan A, Hoffman A. Use of a dynamic in vitro lipolysis model to rationalize oral formulation development for poor water soluble drugs: correlation with in vivo data and the relationship to intra-enterocyte processes in rats. Pharm Res. 2006;23(9):2165–2174. doi:10.1007/s11095-006-9054-x16902814
   PubMed Web of Science ®Google Scholar
• Chen M, Wu Q, Jiang J, et al. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin. J Pharm Biomed Anal. 2017;135:153–159. doi:10.1016/j.jpba.2016.12.02228027523
   PubMedGoogle Scholar
• Ju L, Wenlan W, Qiuwei L, Shan C. Long-circulating nanoliposomes (LCNs) sustained delivery of baicalein (BAI) with desired oral bioavailability in vivo. Drug Deliv. 2013;20(8):319–323. doi:10.3109/10717544.2013.83442024028326
   PubMedGoogle Scholar
• Huang Y, Zhang B, Gao Y, Zhang J, Shi L. Baicalein–nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability. J Pharm Sci. 2014;103(8):2330–2337. doi:10.1002/jps.2404824903146
   PubMedGoogle Scholar
• Feng J, Xu W, Tao X, et al. Simultaneous determination of baicalin, baicalein, wogonin, berberine, palmatine and jatrorrhizine in rat plasma by liquid chromatography–tandem mass spectrometry and application in pharmacokinetic studies after oral administration of traditional Chinese. J Pharm Biomed Anal. 2010;53(3):591–598. doi:10.1016/j.jpba.2010.04.00220430560
   PubMed Web of Science ®Google Scholar
• Jun-Xiao Y, Wang W, Li-Hui Q, Chun-Yu L, Qi C, Yong-Hong L. An LC-MS/MS method for the simultaneous determination of chlorogenic acid, forsythiaside A and baicalin in rat plasma and its application to pharmacokinetic study of shuang-huang-lian in rats. J Pharm Biomed Anal. 2010;52(4):625–630. doi:10.1016/j.jpba.2010.01.03520153596
   PubMedGoogle Scholar
• Ali H, Nazzal M, Zaghloul AAA, Nazzal S. Comparison between lipolysis and compendial dissolution as alternative techniques for the in vitro characterization of α-tocopherol self-emulsified drug delivery systems (SEDDS). Int J Pharm. 2008;352(1):104–114. doi:10.1016/j.ijpharm.2007.10.02318065173
   PubMedGoogle Scholar
• Dahan A, Hoffman A. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci. 2005;24(4):381–388. doi:10.1016/j.ejps.2004.12.00615734305
   PubMed Web of Science ®Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘Self-microemulsifying’ drug delivery systems. Eur J Hosp Pharm. 2000;11(2,supplement):S93–S98. doi:10.1016/S0928-0987(00)00167-6
   Google Scholar